scispace - formally typeset
J

Jinglin Tian

Researcher at Hong Kong Baptist University

Publications -  16
Citations -  532

Jinglin Tian is an academic researcher from Hong Kong Baptist University. The author has contributed to research in topics: In vivo & Internal medicine. The author has an hindex of 7, co-authored 13 publications receiving 366 citations. Previous affiliations of Jinglin Tian include Shenzhen University.

Papers
More filters
Journal ArticleDOI

A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA

TL;DR: The developed nanotherapy formulation here, that combines chemotherapy, RNA silencing and NIR window light-mediated therapy, will be seen to be the next natural step to be taken in the clinical research for improving the therapeutic outcomes of the pancreatic adenocarcinoma treatment.
Journal ArticleDOI

In vivo toxicity assessment of non-cadmium quantum dots in BALB/c mice.

TL;DR: The results manifested that the QDs formulation did not result in observable toxicity in vivo within the evaluation period, thereby suggesting that the InP/ZnS QDs can be utilized as optical probes or nanocarrier for selected in vivo biological applications when an optimized dosage is employed.
Journal ArticleDOI

Immunotoxicity assessment of CdSe/ZnS quantum dots in macrophages, lymphocytes and BALB/c mice

TL;DR: Exposure to CdSe/ZnS QDs could suppress immune-defense against foreign stimuli, which in turn could result in increased susceptibility of hosts to diseases.
Journal ArticleDOI

Folic acid-conjugated organically modified silica nanoparticles for enhanced targeted delivery in cancer cells and tumor in vivo

TL;DR: It is observed that the functionalization of FA onto the particle surface led to a strong cellular uptake of FA-conjugated ORMD nanoparticles for pancreatic cancer Miapaca-2 cells and hepatoma SMMC7721 cells with FA receptor overexpression.